Predicting stock prices is like trying to read the future, and it's a tough challenge for researchers. One popular tool is the long short-term memory neural network (LSTM), which can handle long-term patterns in stock data. But tuning LSTM's settings manually can be tricky and affect how well it wor
Five Nights at Freddy's fans got a sneak peek at a new location in the upcoming sequel, which might shed light on a popular Easter egg from the first movie. If you watched the first film, you know the pizzeria didn't fare so well. But fear not, because a new pizzeria has been spotted in the latest p
Space enthusiasts were thrilled for Sunday's grand event: the launch of Blue Origin's New Glenn rocket. However, their excitement quickly turned into anticipation as technical issues caused repeated delays. Hosts Ariane and Denisse did their best to keep spirits high, but the situation was clearly c
Ever heard of aristolochic acids (AA)? They're sneaky compounds that can cause big problems, like chronic renal disease, worldwide. The main troublemaker is aristolochic acid I (AA-I). Scientists wanted to know why AA-I is so much worse than its cousin, aristolochic acid II (AA-II), even though they
Imagine this: US users, worried about a TikTok ban, are flocking to a Chinese app called Xiaohongshu, also known as RedNote. This app, started in 2013, is a big deal in China, but not so much outside it. Until now, that is. It's like Instagram, but with a twist – it's focused on user interests, not
Eli Lilly, a company based in Indianapolis, recently faced a blow when its stock prices dipped. The reason? Their weight-loss drugs, Zepbound and Mounjaro, didn't sell as well as expected. The company predicted they'd make about $13. 5 billion in the December quarter, which is less than what experts
In November 2024, Rutgers University-New Brunswick hosted the fall meeting of the Theobald Smith Society. Eighty-six members from New Jersey attended, including students, teachers, and professionals from government and industry. This event showcased the wide range of research done by members of the
Ever heard of the "no-show" issue in healthcare? It's when patients book appointments but don't turn up. We looked at this over five years with 21, 969 patients. Our study created a special model to solve this problem. This model not only predicts no-shows but also helps manage service capacity and
Elon Musk isn't a fan favorite in Britain. Polls show he's unpopular, and his social media following has dipped since he took control last October. Yet, when he recently focused on a old child abuse scandal, everyone in Britain paid attention. Why? Well, Musk is super rich and has a friend in the U.
Imagine this: you're having a severe allergic reaction, and suddenly, you have a heart attack. Sounds far-fetched? Not for a man who experienced just that. He had a rare condition called Kounis syndrome, where an extreme allergic reaction, or anaphylaxis, can trigger a heart attack. In his case, it
